Please login to the form below
Vaccitech
This page shows the latest Vaccitech news and features for those working in and with pharma, biotech and healthcare.
UK biotech Vaccitech raises £20m for universal flu shot
Vaccitech has started recruiting volunteers for a phase IIb trial of its candidate that will continue through the 2018/2019 flu season. ... Vaccitech isn’t the only biotech in pursuit of a universal flu vaccine.
Latest news
-
Universal flu vaccine heads for UK trials
The vaccine - developed by University of Oxford spin-out Vaccitech - will be tested in around 500 National Health Service (NHS) patients in a study supported by the National Institute for Health ... Vaccitech’s vaccine is directed against influenza A,
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
Biotech profile: Tom Evans, CEO, Vaccitech.
You took the helm of Vaccitech when it was spun out Oxford University Innovation in 2016. ... He joined Vaccitech in the spring of 2016. He has over 140 authored publications.
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest from PMHub
-
There's power in collaboration
Just look at the success of the Covid-19 vaccine development… from the collaboration between AstraZeneca, Oxford University and it’s Vaccitech company to the partnership between BioNTech, Fosun Pharma and
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- 2023 PM Society Awards – winners announced
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- FDA external report recommends actions to address US opioid crisis
- MHRA to introduce new UK clinical trials framework
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Inizio appoints Stefanie Christmas as global head of DE&I
- Rare diseases: not so rare after all
- Sanofi/Regeneron’s Dupixent shows promise in atopic hand and foot dermatitis
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Dermavant reports positive phase 3 results for Vtama cream in atopic dermatitis
- Pfizer/BioNTech’s Omicron-adapted booster approved by FDA for young children
- Havas Health & You appoints Alex Okada as chief creative officer of Havas Lynx Group
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
